JK
Jatinder Kaur
Molecular Quest Healthcare Pvt Ltd, All India Institute of Medical Sciences, Mount Sinai Hospital
0000-0003-1650-0707
Employment
-
Molecular Quest Healthcare Pvt Ltd Director2013 - Present
-
All India Institute of Medical Sciences Research Associate2012 - 2013
-
Mount Sinai Hospital Research Associate2010 - 2011
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (42)
- Study of tumor transglutaminase 2 expression in gallbladder cancer – Is it a novel predictor of survival? Save
- Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis. Save
- Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. Save
- Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients. Save
- Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer. Save
- S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Save
- Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. Save
- Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas. Save
- Biotinidase is a novel marker for papillary thyroid cancer aggressiveness. Save
- Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma. Save